Summary
JD Pharma is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €514,700 and a net result of €48,565. Equity is growing by about 35% per year across the filed financial years. Its solvency ranks better than 34% of 9,732 sector peers (NACE 64, financial year 2025). The company has been active since 2015 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
28-08
NBB filing
Annual accounts filed
financial year 2025 · micro format · 28 days late
2025
31-12
Financial
Equity above €500,000equity €514,700 ▲10.4%
A profit in every financial year since 2018 builds equity to €514,700.
24-07
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
19-07
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
31-12
Financial
Highest result from 2018 to 2025net €221,286 ▲559%
Operating result €304,732, net result €221,286, both a record.
31-12
Financial
Equity above €200,000equity €406,361 ▲120%
A profit in every financial year since 2018 builds equity to €406,361.
06-12
Gazette deed
Legal-form change · Resignations & appointmentsCapital · Capital conversion · Purpose change6 facts ▸
Gazette deed
Legal-form change · Resignations & appointments
Capital · Capital conversion · Purpose change6 facts ▸
- General meeting, 10-11-2023
- Other provision, “aanpassing statuten aan WVV en behoud rechtsvorm, statuten aanpassen” (deed in Dutch)
- Capital
- Capital conversion, “beschikbaar voor toekomstige uitkeringen” (deed in Dutch)
- Purpose change
- Amendment of the articles
12-07
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
31-08
NBB filing
Annual accounts filed
financial year 2021 · micro format · 31 days late
2021
31-12
Financial
Equity above €150,000equity €151,518 ▲33.5%
A profit in every financial year since 2018 builds equity to €151,518.
08-07
NBB filing
Annual accounts filed
financial year 2020 · micro format
2020
31-12
Financial
Liquidity more than doubledcurrent ratio 4.23
Current ratio from 1.49 to 4.23; short-term debt falls from €37,146 to €16,963.
Show earlier events
31-12
Financial
Equity above €100,000equity €113,487 ▲36.5%
A profit in every financial year since 2018 builds equity to €113,487.
25-08
NBB filing
Annual accounts filed
financial year 2019 · micro format · 25 days late
2019
11-07
NBB filing
Annual accounts filed
financial year 2018 · micro format
2018
29-08
NBB filing
Annual accounts filed
financial year 2017 · abbreviated format · 29 days late
2017
28-08
NBB filing
Annual accounts filed
financial year 2016 · abbreviated format · 28 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 2 deeds read
About the unread acts
Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.